You might also like
Cellebrite DI Ltd. (CLBT) is a global provider of digital intelligence solutions, specializing in software and services that help law enforcement agencies, government entities, and private organizations collect, analyze, and manage digital data for investigative purposes. The company primarily sells subscription-based software solutions, along with professional services and other non-recurring products.
-
Subscription Revenue - Offers subscription services and term-license agreements for software solutions, enabling customers to access digital intelligence tools over a defined period.
- Subscription Services - Provides ongoing access to software tools for the duration of the subscription.
- Term-License Revenue - Grants immediate access to on-premise software licenses upon purchase.
-
Professional Services Revenue - Delivers training, advanced services, implementation support, and on-premise customer assistance to enhance the use of its digital intelligence solutions.
-
Other Non-Recurring Revenue - Includes hardware sales, perpetual licenses, and usage-based fees for customers seeking one-time or specialized solutions.
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Thomas E. Hogan ExecutiveBoard | Interim Chief Executive Officer | Thomas E. Hogan, with over 40 years of industry experience, has been serving as the Interim Chief Executive Officer at Cellebrite since January 1, 2025 and as a Director since August 2023. He has previously held senior roles at companies such as IBM, Siebel Systems, and Kony, Inc.. | View Report → | |
Ayala Berler Shapira Executive | General Counsel & Chief Compliance Officer | Ayala Berler Shapira has been serving as the General Counsel & Chief Compliance Officer at Cellebrite since September 2022, and she previously served as Deputy General Counsel at Amdocs (2011-2022) and General Counsel at Jungo (2006-2011). | ||
Dana Gerner Executive | Chief Financial Officer (CFO) | Dana Gerner has been the Chief Financial Officer (CFO) of Cellebrite DI Ltd. since May 2014, bringing over 25 years of financial leadership experience from roles at Polymer Logistics and Leiman Schlussel. | ||
David Gee Executive | Chief Marketing Officer | David Gee has been the Chief Marketing Officer at Cellebrite since March 25, 2024, bringing over 25 years of technology sales and marketing leadership experience. Previously, he served as CMO at Coherent Inc. from 2020 to 2022 and held senior marketing roles at companies such as Imperva, Zuora, Infoblox, Hewlett-Packard, Yahoo!, Sun Microsystems, and IBM. | ||
Marcus Jewell Executive | Chief Revenue Officer (CRO) | Marcus Jewell is the Chief Revenue Officer at CLBT since November 2023, where he oversees global sales for both public and private sectors. He brings over 25 years of senior-level sales and management expertise and has previously served as CRO at CSS LLC and Juniper Networks, in addition to holding leadership roles at Brocade and Mitel. | ||
Ronnen Armon Executive | Chief Products & Technologies Officer (CPTO) | Ronnen Armon is the Chief Products & Technologies Officer at Cellebrite, a role he has held since July 2020. He oversees the company’s solutions, products, and technology, and has previously held leadership roles at companies including Verbit.ai, Capriza, HP Software, and Mercury Interactive. | ||
Sigalit Shavit Executive | Chief Information Officer (CIO) | Sigalit Shavit has served as the Chief Information Officer (CIO) at CLBT since August 1, 2024, and brings over 30 years of IT and security experience. Previously, she held executive roles at other companies, including Global CIO at CyberArk and leadership positions at KTrust Security, ECI Telecom, and FedEx Israel. | ||
Zohar Tadmor-Eilat Executive | Chief People Officer | Zohar Tadmor-Eilat is the Chief People Officer at Cellebrite, a role she has held since joining the company though the start date is not specified. Previously, she served in key HR executive roles including Global Vice President of Human Resources at CyberArk and BitTech/BetaMedia, demonstrating her extensive background in human resources. |
- Considering your decision to exit certain countries, which is expected to modestly impact Q1 results and only slightly improve gross retention rates, can you elaborate on the strategic rationale behind this move and how you plan to mitigate the associated revenue loss in the near term?
- With the U.S. federal government accounting for 20% of your revenue and current geopolitical changes causing purchase delays, how confident are you in achieving your 2025 ARR and revenue guidance, and what strategies are in place to address prolonged federal spending uncertainties?
- Despite a strong ARR growth, the magnitude of your EBITDA beat was lower this quarter compared to previous ones, and your Q1 guidance aligns with Street expectations; what factors are contributing to this trend, and how do you plan to enhance your profitability margins moving forward?
- You aim to migrate 50% of your installed base to Inseyets by the end of 2025, yet only 20% have migrated so far; what challenges are you facing in accelerating this migration, and what specific actions are you taking to ensure you meet this ambitious target?
- With the CEO search still ongoing and interim leadership in place, how might this leadership transition impact your execution of strategic initiatives like expanding into the U.S. federal sector and advancing your cloud and AI offerings, and what measures are you taking to ensure continuity during this period?
Notable M&A activity and strategic investments in the past 3 years.
| Company | Year | Details |
|---|---|---|
Cyber Technology Services, Inc. (CyTech) | 2024 | Cellebrite acquired CyTech for $3.75 million in July 2024, integrating its U.S. cybersecurity, digital forensics, and incident response capabilities into the newly formed Cellebrite Federal Solutions unit to broaden its relationship with the U.S. federal government. The acquisition, though contributing de minimis revenue initially (with Q3 2024 contributions slightly below $0.5M), is expected to yield financial benefits starting in 2025 and supports Cellebrite's long-term growth in the federal marketplace. |
No recent press releases or 8-K filings found for CLBT.